Abstract
Entekavir, Hepatit B enfeksiyonunun tedavisinde kullanılan önemli bir nükleozid analoğudur. Bu olgu sunumunda, entekavir tedavisi alırken bilateral jinekomasti ve mastodoni gelişen bir olgu sunulması amaçlanmıştır.
Keywords
References
- 1. Karagoz E, Selek MB, Tanoglu A, Hatipoglu M, Ulçay A, Turhan V. Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in patients with chronic hepatitis B. Infez Med. 2016;24(4):287-292.
- 2. Karagöz E, Tanoğlu A. Importance of serum hepatitis B surface antigen and hepatitis e antigen quantification among patients with chronic hepatitis B. Turk J Gastroenterol. 2015;26:357.
- 3. Nikolopoulou GB, Tzoutzas I, Tsakris A, Maltezou HC. Hepatitis B in healthcare personnel: an update on the global landscape. Viruses. 2023;15(12):2454. doi: 10.3390/v15122454
- 4. Karagoz E, Ulcay A, Tanoglu A, et al. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol. 2014;26(12):1320-1324.
- 5. Koklu S, Gulsen MT, Tuna Y, et al. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B. Aliment Pharmacol Ther. 2015;41(3):310-319.
- 6. Deepinder F, Braunstein GD. Drug-induced gynecomastia: an evidence-based review. Expert Opin Drug Saf. 2012;11(5):779-795. doi: 10.1517/14740338.2012.712109
- 7. Berger O, Landau Z, Talisman R. Gynecomastia: a systematic review of pharmacological treatments. Front Pediatr. 2022;10:978311. doi: 10.3389/fped.2022.978311
- 8. Henriquez-Camacho C, Hijas-Gomez AI, Risco Risco C, Ruiz Lapuente MA, Escudero-Sanchez R, Cuerda VM. Lamivudine and entecavir for acute hepatitis B: a systematic review and meta-analysis. Viruses. 2023;15(11):2241. doi: 10.3390/v15112241
- 9. Bayramıçlı OU, Ahishali E, Dabak R, Ak Ö, Dolapçioğlu C. A case of gynecomastia due to entecavir. Turk J Gastroenterol. 2010;21(3):313-316. doi: 10.4318/tjg.2010.0108
Abstract
Entecavir is an important nucleoside analogue that plays a pivotal role in the treatment of Hepatitis B infection. In this case report, it was aimed to present a case regarding bilateral gynecomastia and mastodonia while receiving entecavir treatment.
Keywords
References
- 1. Karagoz E, Selek MB, Tanoglu A, Hatipoglu M, Ulçay A, Turhan V. Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in patients with chronic hepatitis B. Infez Med. 2016;24(4):287-292.
- 2. Karagöz E, Tanoğlu A. Importance of serum hepatitis B surface antigen and hepatitis e antigen quantification among patients with chronic hepatitis B. Turk J Gastroenterol. 2015;26:357.
- 3. Nikolopoulou GB, Tzoutzas I, Tsakris A, Maltezou HC. Hepatitis B in healthcare personnel: an update on the global landscape. Viruses. 2023;15(12):2454. doi: 10.3390/v15122454
- 4. Karagoz E, Ulcay A, Tanoglu A, et al. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol. 2014;26(12):1320-1324.
- 5. Koklu S, Gulsen MT, Tuna Y, et al. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B. Aliment Pharmacol Ther. 2015;41(3):310-319.
- 6. Deepinder F, Braunstein GD. Drug-induced gynecomastia: an evidence-based review. Expert Opin Drug Saf. 2012;11(5):779-795. doi: 10.1517/14740338.2012.712109
- 7. Berger O, Landau Z, Talisman R. Gynecomastia: a systematic review of pharmacological treatments. Front Pediatr. 2022;10:978311. doi: 10.3389/fped.2022.978311
- 8. Henriquez-Camacho C, Hijas-Gomez AI, Risco Risco C, Ruiz Lapuente MA, Escudero-Sanchez R, Cuerda VM. Lamivudine and entecavir for acute hepatitis B: a systematic review and meta-analysis. Viruses. 2023;15(11):2241. doi: 10.3390/v15112241
- 9. Bayramıçlı OU, Ahishali E, Dabak R, Ak Ö, Dolapçioğlu C. A case of gynecomastia due to entecavir. Turk J Gastroenterol. 2010;21(3):313-316. doi: 10.4318/tjg.2010.0108
Details
| Primary Language | English |
|---|---|
| Subjects | Gastroenterology and Hepatology |
| Journal Section | Letter to the Editor [en] Editöre Mektup [tr] |
| Authors | |
| Publication Date | April 30, 2024 |
| Submission Date | March 31, 2024 |
| Acceptance Date | April 25, 2024 |
| Published in Issue | Year 2024 Volume: 5 Issue: 2 |
TR DİZİN ULAKBİM and International Indexes (1d)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
| ||
|
|
|
|
|
|
|
|
Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.
EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation.
Journal articles are evaluated as "Double-Blind Peer Review".